Where Are We Now? Product Pipeline, and Clinical Trial Update with Jerry Siegel PharmD, FASHP

[et_pb_ld_video _builder_version=”3.1″][/et_pb_ld_video]
Speaker:  Jerry Siegel PharmD, FASHP

Jerry Siegel retired in 2009 as the Senior Director for Pharmaceutical Services for the Ohio State University Medical Center and Assistant Dean for the Ohio State University College of Pharmacy. He is still a clinical associate professor at the College of Pharmacy. He graduated from the Ohio State University with his B.S in microbiology and B.S. and Pharm.D. from the College of Pharmacy. Previously a clinical microbiologist he worked as a clinical pharmacist in transplantation and hematology/ oncology before focusing on administration. He has had over 100 invited presentations and publications in the area of immunology and infectious disease. In 1995 he received the designation of Fellow of the American Society of Health-System Pharmacists. Dr. Siegel is the recipient of the 2011 American Society of Health System Pharmacists Distinguished Leadership Award

Currently he is Vice President and managing partner of Safe Medication Management Associates Inc. (SMMA) consulting firm.

In 2014, Dr. Siegel was part of the team that received the ASHP/Cardinal National Safety Award and $50,000 grant at the ASHP midyear clinical meeting for the project at the Yale-New Haven Hospital on Tele-pharmacy. Dr. Siegel™s focus for the past five years has been designing and building pharmacy infusion centers and assuring and training staff compliance with USP <797> and <800> chapters. He has also provided lectures on the use of IVIG and Rabies immune globulin throughout the United States at state and local pharmacy associations.

Most recently Dr. Siegel has been providing COVID-19 vaccinations at long term care facilities throughout Ohio as he is an APhA Certified immunizer and a member of the Medical Reserve Corp.